BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29507752)

  • 1. Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison.
    Mehta RT; Pareek A; Purkait I
    Clin Hypertens; 2018; 24():4. PubMed ID: 29507752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?
    Jonnalagadda VG; Choudhary K; Matety VK
    Clin Hypertens; 2017; 23():27. PubMed ID: 29234523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trial.
    Oh GC; Lee HY; Chung WJ; Youn HJ; Cho EJ; Sung KC; Chae SC; Yoo BS; Park CG; Hong SJ; Kim YK; Hong TJ; Choi DJ; Hyun MS; Ha JW; Kim YJ; Ahn Y; Cho MC; Kim SG; Shin J; Park S; Sohn IS; Kim CJ
    Clin Hypertens; 2017; 23():18. PubMed ID: 28879040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
    Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
    Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients.
    Toh N; Ishii K; Kihara H; Iwakura K; Watanabe H; Yoshikawa J; Ito H;
    Circ J; 2016; 80(2):426-34. PubMed ID: 26725762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
    Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
    Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension.
    Shiga Y; Miura SI; Motozato K; Yoshimine Y; Norimatsu K; Arimura T; Koyoshi R; Morii J; Kuwano T; Inoue K; Shirotani T; Fujisawa K; Matsunaga E; Saku K
    J Clin Med Res; 2017 Feb; 9(2):98-103. PubMed ID: 28090225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring.
    Pareek AK; Messerli FH; Chandurkar NB; Dharmadhikari SK; Godbole AV; Kshirsagar PP; Agarwal MA; Sharma KH; Mathur SL; Kumbla MM
    J Am Coll Cardiol; 2016 Feb; 67(4):379-389. PubMed ID: 26821625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrochlorothiazide is not the most useful nor versatile thiazide diuretic.
    Vongpatanasin W
    Curr Opin Cardiol; 2015 Jul; 30(4):361-5. PubMed ID: 26049382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis.
    Agarwal R; Weir MR
    J Hypertens; 2013 Aug; 31(8):1692-701. PubMed ID: 23697963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.
    Martins VM; Helal L; Ferrari F; Bottino LG; Fuchs SC; Fuchs FD
    Trials; 2019 Dec; 20(1):736. PubMed ID: 31843024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
    Stergiou GS; Makris T; Papavasiliou M; Efstathiou S; Manolis A
    J Hypertens; 2005 Apr; 23(4):883-9. PubMed ID: 15775795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior antihypertensive and cardioprotective effects of chlorthalidone compared with hydrochlorothiazide.
    Chrysant SG; Chrysant GS
    Drugs Today (Barc); 2021 Apr; 57(4):291-301. PubMed ID: 33851692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a pragmatic clinical trial embedded in the Electronic Health Record: The VA's Diuretic Comparison Project.
    Ishani A; Leatherman SM; Woods P; Hau C; Klint A; Lew RA; Taylor AA; Glassman PA; Brophy MT; Fiore LD; Ferguson RE; Cushman WC
    Contemp Clin Trials; 2022 May; 116():106754. PubMed ID: 35390512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effect of combination therapy with an angiotensin II receptor blocker and either a low-dose diuretic or calcium channel blocker on cardiac hypertrophy in patients with hypertension.
    Okura T; Miyoshi K; Irita J; Enomoto D; Jotoku M; Nagao T; Watanabe K; Matsuoka H; Ashihara T; Higaki J;
    Clin Exp Hypertens; 2013; 35(8):563-9. PubMed ID: 23402476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
    Omboni S; Malacco E; Napoli C; Modesti PA; Manolis A; Parati G; Agabiti-Rosei E; Borghi C
    Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.